Winning Points Advisors, LLC Merck & Co., Inc. Transaction History

Winning Points Advisors, LLC

$68.7 Million
Q3 2024

A detailed history of Winning Points Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Winning Points Advisors, LLC holds 3,222 shares of MRK stock, worth $315,917. This represents 0.53% of its overall portfolio holdings.

Number of Shares

3,222

Previous 3,422 5.84%

Holding current value

$315,917

Previous $451,000 19.07%

% of portfolio

0.53%

Previous 0.69%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$111.15 - $128.97 $22,230 - $25,794	-200 Reduced 5.84%	3,222 $365,000
Q4 2023 Nov 14, 2024	BUY	$100.18 - $109.02 $20,036 - $21,804	200 Added 6.21%	3,422 $373,000
Q3 2023 Nov 14, 2024	SELL	$102.95 - $114.33 $20,590 - $22,866	-200 Reduced 5.84%	3,222 $331,000
Q2 2023 Nov 14, 2024	BUY	$108.61 - $118.38 $1,411 - $1,538	13 Added 0.38%	3,422 $394,000
Q1 2023 Apr 21, 2023	BUY	$102.94 - $114.86 $102 - $114	1 Added 0.03%	3,409 $363,000
Q4 2022 Feb 10, 2023	SELL	$87.44 - $112.11 $17,575 - $22,534	-201 Reduced 5.57%	3,408 $378,000
Q3 2022 Oct 07, 2022	SELL	$84.53 - $94.96 $1,014 - $1,139	-12 Reduced 0.33%	3,609 $313,000
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $83,490 - $94,640	-1,000 Reduced 21.64%	3,621 $330,000
Q1 2022 Apr 27, 2022	SELL	$73.51 - $82.4 $253,462 - $284,115	-3,448 Reduced 42.73%	4,621 $379,000
Q4 2021 Feb 16, 2022	BUY	$72.28 - $90.54 $249,221 - $312,181	3,448 Added 74.62%	8,069 $677,000
Q3 2021 Nov 17, 2021	BUY	$71.68 - $78.83 $40,355 - $44,381	563 Added 13.87%	4,621 $347,000
Q2 2021 Aug 16, 2021	SELL	$70.31 - $77.77 $100,332 - $110,977	-1,427 Reduced 26.02%	4,058 $316,000
Q1 2021 May 13, 2021	BUY	$68.86 - $81.11 $27,612 - $32,525	401 Added 7.89%	5,485 $423,000
Q4 2020 Feb 01, 2021	SELL	$71.77 - $79.65 $197,367 - $219,037	-2,750 Reduced 35.1%	5,084 $396,000
Q3 2020 Nov 13, 2020	SELL	$73.18 - $82.95 $14,636 - $16,590	-200 Reduced 2.49%	7,834 $650,000
Q1 2020 Apr 14, 2020	SELL	$63.36 - $87.82 $2,217 - $3,073	-35 Reduced 0.43%	8,034 $618,000
Q4 2018 Nov 12, 2019	BUY	$65.24 - $75.71 $58,715 - $68,139	900 Added 12.55%	8,069 $610,000
Q3 2018 Feb 02, 2021	SELL	$57.69 - $67.84 $57,690 - $67,840	-1,000 Reduced 12.24%	7,169 $509,000
Q3 2018 Nov 12, 2019	SELL	$57.69 - $67.84 $11,538 - $13,568	-200 Reduced 2.39%	8,169 $580,000
Q4 2017 Nov 12, 2019	SELL	$51.62 - $61.64 $6,452 - $7,705	-125 Reduced 1.47%	8,369 $471,000
Q3 2017 Nov 12, 2019	BUY	$58.67 - $63.13 $23,468 - $25,252	400 Added 4.94%	8,494 $518,000
Q2 2017 Nov 08, 2019	SELL	N/A	-400 Reduced 4.71%	8,094 $520,000
Q4 2016 Nov 07, 2019	BUY	N/A	8,494	8,494 $500,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winning Points Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Winning Points Advisors, LLC with notifications on news.

Account

Winning Points Advisors, LLC Merck & Co., Inc. Transaction History